English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Aids Institute
John Breslin
| Oct 27, 2017
CMS administrator urged to prevent states from restricting hepatitis C drug access
Nicholas Gueguen
| Aug 13, 2017
House Appropriations Committee decides to keep funding for several programs in HIV, hepatitis fight
Robert Hadley
| Jun 2, 2017
FDA approves higher once-a-day dose of Merck’s Isentress HIV drug
Erianne Leatherman
| May 16, 2017
AIDS Alliance working with Advocates for Youth to boost AIDS/HIV awareness
Erianne Leatherman
| Mar 15, 2017
Updates to National Viral Hepatitis Action Plan include strategies to prevent infection
Vimbai Chikomo
| Apr 6, 2016
Obamacare is failing to discipline Florida insurers for discriminating against hepatitis C patients, according to expert
Jamie Barrand
| Dec 24, 2015
The AIDS Institute officials laud rejection of HIV funding cuts
Katelyn Kivel
| Nov 3, 2015
Cigna leaves Florida exchange amid HIV discrimination allegations
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
